APA (7th ed.) Citation

G, A., A, D., S, Y., O, K., ME, M., O, A., . . . N, T. (2024). Exploring the Clinical Impact of RANK Pathway Inhibition in Advanced Breast Cancer: Insights From a Retrospective Study on CDK4/6 Inhibitors and Antiresorptive Therapy. Cureus, 16(6), e63362. https://doi.org/10.7759/cureus.63362

Chicago Style (17th ed.) Citation

G, Akdag, et al. "Exploring the Clinical Impact of RANK Pathway Inhibition in Advanced Breast Cancer: Insights From a Retrospective Study on CDK4/6 Inhibitors and Antiresorptive Therapy." Cureus 16, no. 6 (2024): e63362. https://doi.org/10.7759/cureus.63362.

MLA (9th ed.) Citation

G, Akdag, et al. "Exploring the Clinical Impact of RANK Pathway Inhibition in Advanced Breast Cancer: Insights From a Retrospective Study on CDK4/6 Inhibitors and Antiresorptive Therapy." Cureus, vol. 16, no. 6, 2024, p. e63362, https://doi.org/10.7759/cureus.63362.